全文获取类型
收费全文 | 1985篇 |
免费 | 102篇 |
国内免费 | 26篇 |
专业分类
耳鼻咽喉 | 36篇 |
儿科学 | 91篇 |
妇产科学 | 14篇 |
基础医学 | 253篇 |
口腔科学 | 59篇 |
临床医学 | 246篇 |
内科学 | 473篇 |
皮肤病学 | 34篇 |
神经病学 | 87篇 |
特种医学 | 172篇 |
外科学 | 282篇 |
综合类 | 56篇 |
预防医学 | 69篇 |
眼科学 | 17篇 |
药学 | 92篇 |
中国医学 | 3篇 |
肿瘤学 | 129篇 |
出版年
2023年 | 16篇 |
2022年 | 33篇 |
2021年 | 50篇 |
2020年 | 26篇 |
2019年 | 33篇 |
2018年 | 44篇 |
2017年 | 30篇 |
2016年 | 33篇 |
2015年 | 35篇 |
2014年 | 71篇 |
2013年 | 64篇 |
2012年 | 92篇 |
2011年 | 114篇 |
2010年 | 80篇 |
2009年 | 58篇 |
2008年 | 84篇 |
2007年 | 122篇 |
2006年 | 108篇 |
2005年 | 94篇 |
2004年 | 72篇 |
2003年 | 62篇 |
2002年 | 59篇 |
2001年 | 45篇 |
2000年 | 34篇 |
1999年 | 56篇 |
1998年 | 54篇 |
1997年 | 47篇 |
1996年 | 40篇 |
1995年 | 24篇 |
1994年 | 32篇 |
1993年 | 24篇 |
1992年 | 29篇 |
1991年 | 20篇 |
1990年 | 23篇 |
1989年 | 19篇 |
1988年 | 42篇 |
1987年 | 21篇 |
1986年 | 22篇 |
1985年 | 13篇 |
1984年 | 25篇 |
1983年 | 20篇 |
1982年 | 18篇 |
1981年 | 14篇 |
1980年 | 10篇 |
1979年 | 10篇 |
1978年 | 8篇 |
1977年 | 8篇 |
1976年 | 11篇 |
1973年 | 12篇 |
1969年 | 11篇 |
排序方式: 共有2113条查询结果,搜索用时 15 毫秒
1.
Rajendrababu Sharmila Puthuran George Varghese Alia Laxmi Ananya Uduman Mohammed Sithiq Wijesinghe Hiruni Kaushalya 《International ophthalmology》2022,42(8):2609-2618
International Ophthalmology - To investigate the efficacy and safety of non-valved Aurolab aqueous drainage implant (AADI) surgery combined with phacoemulsification in eyes with refractory glaucoma... 相似文献
2.
Sebastian Mondaca Walid K. Chatila David Bates Jaclyn F. Hechtman Andrea Cercek Neil H. Segal Zsofia K. Stadler Anna M. Varghese Ritika Kundra Marinela Capanu Jinru Shia Nikolaus Schultz Leonard Saltz Rona Yaeger 《Clinical colorectal cancer》2019,18(1):e39-e52
Background
Treatment of advanced anal squamous cell cancer (SCC) is usually with the combination of cisplatin and 5-fluorouracil, which is associated with heterogeneous responses across patients and significant toxicity. We examined the safety and efficacy of a modified schedule, FOLFCIS (leucovorin, fluorouracil, and cisplatin), and performed an integrated clinical and genomic analysis of anal SCC.Patients and Methods
We reviewed all patients with advanced anal SCC receiving first-line FOLFCIS chemotherapy – essentially a FOLFOX (leucovorin, fluorouracil, and oxaliplatin) schedule with cisplatin substituted for oxaliplatin – in our institution between 2007 and 2017, and performed deep sequencing to identify genomic markers of response and key genomic drivers.Results
Fifty-three patients with advanced anal SCC (48 metastatic; 5 unresectable, locally advanced) received first-line FOLFCIS during this period; all were platinum-naive. The response rate was 48% (95% confidence interval [CI], 32.6%-63%). With a median follow-up of 41.6 months, progression-free survival and overall survival were 7.1 months (95% CI, 4.4-8.6 months) and 22.1 months (95% CI, 16.9-28.1 months), respectively. Among all patients with advanced anal SCC that underwent sequencing during the study period, the most frequent genomic alterations consisted of chromosome 3q amplification (51%) and mutations in PIK3CA (29%) and KMT2D (22%). No genomic alteration correlated with response to platinum-containing treatment. Although there were few cases, patients with human papillomavirus-negative anal SCC did not appear to benefit from FOLFCIS, and all harbored distinct genomic profiles with TP53, TERT promoter, and CDKN2A mutations.Conclusions
FOLFCIS appears effective and safe as first-line chemotherapy in patients with advanced anal SCC and represents an alternative treatment option for these patients. 相似文献3.
Dr. Arni Raghavendrarao Raghuram M.Ch. Subbiah Kumar MD Kathamuthu Balamurugan DA Arulmurugan DA Ramiah Krishnan M.Ch. Perichiappan Sivakami BS Eluvathingal Varghese John M.Ch. 《Indian Journal of Thoracic and Cardiovascular Surgery》2006,22(3):178-181
Background Beating heart surgery has now become the commonest technique of doing Coronary Artery Bypass Graft Surgery (CABG) in our country.
It is being used even in such high risk situations like diffuse coronary disease and Critical Left Main stem Stenosis (LMCS)
with good results. The aim of this study is to retrospectively review our results in Off-Pump Coronary Artery Bypass Surgery
(OPCAB) in patients with critical left main stem stenosis.
Methods This study is a retrospective analysis of the data of patients who underwent primary coronary artery bypass surgery. During
the period from April 2003 to September 2005 a total of 64 patients underwent OPCAB procedure for critical LMCS. During the
same period 10 patients underwent CABG on Cardio Pulmonary Bypass (CPB). The age range was 36–77yrs. The sex distribution
was M: F 53∶10. Ten patients were done as emergency. 2 of them were on Intra Aortic Balloon Pump (IABP) support preoperatively.
10 patients were high risk with a Euro score of ≥5.
Results Left Internal Mammary Artery (LIMA) was used in 78% of cases. Average grafts per patient was 2.96. The median ventilation
time was 5.91 hrs. New IABP insertion in postoperative period was required in 1 patient. One patient was reexplored for bleeding.
There was one perioperative myocardial infarction. 57% of patients did not need any blood transfusion. There was no conversion
to CPB. There was no operative mortality. Inotropes were used in ten cases.
Conclusions OPCAB is a safe method of revascularization in patients with critical LMCS. Preoperative IABP is useful in patients with cardiogenic
shock. However, there is a place for CPB in patients needing additional procedures like Mitral Valve repair (MV repair) or
Dor's procedure or when the vessels are very diffusely diseased. Those patients who are unstable despite IABP support may
be managed by Beating heart On Pump (BHOP) technique. 相似文献
4.
Factors influencing women to undergo screening mammography 总被引:2,自引:0,他引:2
5.
Braffman BH; Coleman BG; Ramchandani P; Arger PH; Nodine CF; Dinsmore BJ; Louie A; Betsch SE 《Radiology》1994,190(3):797
6.
7.
8.
Mo Therese Hannah Ellen R. Gritz David K. Wellisch Pat Fobair Richard T. Hoppe Joan R. Bloom Guo-Wen Sun Anna Varghese Malcolm D. Cosgrove David Spiegel 《Psycho-oncology》1992,1(2):89-103
This study compares the effects of the cancer experience on various aspects of marital and sexual functioning (e.g., communication, emotional support, body image, sexual satisfaction and frequency) for two groups of long-term cancer survivors (testicular cancer and Hodgkin's disease) and their spouses. Comparisons between the two patient groups showed significantly more survivors of Hodgkin's disease than testicular cancer reporting the emergence of special issues and changes in the marital relationship. No differences emerged between the spouse groups on sexual functioning variables; however, spouses of survivors of Hodgkin's disease were more likely than spouses of survivors of testicular cancer to report the development of special issues and communication difficulties. A substantial proportion of both survivor groups disclosed negative changes in body image and sexual frequency. Majorities of both survivors and spouses acknowledged that the illness had drawn them closer together. When representative marital/sexual functioning variables were used to predict Family Environment Scale (FES) scores for survivors and for spouses, changes in the spouse's importance, influence of the illness on the relationship, and changes in sexual frequency emerged as significant predictors. The clinical significance of long-term changes in marital and sexual functioning for the couple and the need for therapeutic interventions are discussed. 相似文献
9.
Rupture of the distal biceps tendon: evaluation with MR imaging 总被引:2,自引:0,他引:2
10.
Anne M Lewis Sheelu Varghese Hui Xu H Richard Alexander 《Journal of translational medicine》2006,4(1):48
The tumor microenvironment consists of tumor, immune, stromal, and inflammatory cells which produce cytokines, growth factors,
and adhesion molecules that promote tumor progression and metastasis. Of particular interest in this setting is interleukin-1
(IL-1), a pleiotropic cytokine with numerous roles in both physiological and pathological states. It is known to be up regulated
in many tumor types and has been implicated as a factor in tumor progression via the expression of metastatic and angiogenic
genes and growth factors. A number of studies have reported that high IL-1 concentrations within the tumor microenvironment
are associated with a more virulent tumor phenotype. Solid tumors in which IL-1 has been shown to be up regulated include
breast, colon, lung, head and neck cancers, and melanomas, and patients with IL-1 producing tumors have generally bad prognoses.
The exact mechanisms by which IL-1 promotes tumor growth remain unclear, though the protein is believed to act via induction
of pro-metastatic genes such as matrix metalloproteinases and through the stimulation of adjacent cells to produce angiogenic
proteins and growth factors such as VEGF, IL-8, IL-6, TNFα, and TGFβ. The IL-1 receptor antagonist (IL-1ra) is a naturally
occurring inhibitor to IL-1 and acts by binding to the IL-1 receptor without activating it. The protein has been shown to
decrease tumor growth, angiogenesis, and metastases in murine xenograft models. Our focus in this review is to summarize the
known data on the role of IL-1 in tumor progression and metastasis and the use of IL-1 inhibition as a novel therapeutic approach
in the treatment of solid organ malignancies. 相似文献